These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29715185)

  • 1. Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model.
    Wihastuti TA; Heriansyah T; Hanifa H; Andarini S; Sholichah Z; Sulfia YH; Adam AA; Refialdinata J; Lutfiana NC
    Endocr Regul; 2018 Apr; 52(2):69-75. PubMed ID: 29715185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lp-PLA
    Wihastuti TA; Aini FN; Tjahjono CT; Sulfia YH; Sholichah Z; Heriansyah T
    Vasc Health Risk Manag; 2019; 15():503-508. PubMed ID: 31802883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis.
    Heriansyah T; Nafisatuzzamrudah N; Aini FN; Ridwan M; Primardhika RF; Wijayanti M; Bekti RS; Wihastuti TA
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):114-119. PubMed ID: 30394217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.
    Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH
    Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lipoprotein-associated phospholipase A2 inhibitor on insulin resistance in streptozotocin-induced diabetic pregnant rats.
    Wang GH; Jin J; Sun LZ
    Endocr J; 2018 Sep; 65(9):903-913. PubMed ID: 29925744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice.
    Hu MM; Zhang J; Wang WY; Wu WY; Ma YL; Chen WH; Wang YP
    Acta Pharmacol Sin; 2011 Oct; 32(10):1253-8. PubMed ID: 21970837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity in Japanese dyslipidemic patients, with exploratory analysis of a PLA2G7 gene polymorphism of Val279Phe.
    Daida H; Iwase T; Yagi S; Ando H; Nakajima H
    Circ J; 2013; 77(6):1518-25. PubMed ID: 23439604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic plaque inflammation varies between vascular sites and correlates with response to inhibition of lipoprotein-associated phospholipase A2.
    Fenning RS; Burgert ME; Hamamdzic D; Peyster EG; Mohler ER; Kangovi S; Jucker BM; Lenhard SC; Macphee CH; Wilensky RL
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25672369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective lipoprotein-associated phospholipase A2 inhibitor darapladib triggers irreversible actions on glioma cell apoptosis and mitochondrial dysfunction.
    Wang YJ; Chang SB; Wang CY; Huang HT; Tzeng SF
    Toxicol Appl Pharmacol; 2020 Sep; 402():115133. PubMed ID: 32668280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A
    Zhuo S; Yuan C
    Sci Rep; 2020 Oct; 10(1):17232. PubMed ID: 33057060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inhibition of lipoprotein-associated phospholipase A
    Prasad M; Lennon R; Barsness GW; Prasad A; Gulati R; Lerman LO; Lerman A
    Int J Cardiol; 2018 Feb; 253():7-13. PubMed ID: 29306475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease.
    Riley RF; Corson MA
    IDrugs; 2009 Oct; 12(10):648-55. PubMed ID: 19790016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].
    Chen J; Cai HW; Miao J; Xu XM; Mao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active vitamin D3, 1,25-(OH)2D3, protects against macrovasculopathy in a rat model of type 2 diabetes mellitus.
    Ma R; Deng XL; Du GL; Li C; Xiao S; Aibibai Y; Zhu J
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA
    Acharya NK; Qi X; Goldwaser EL; Godsey GA; Wu H; Kosciuk MC; Freeman TA; Macphee CH; Wilensky RL; Venkataraman V; Nagele RG
    Diab Vasc Dis Res; 2017 May; 14(3):200-213. PubMed ID: 28301218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
    Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
    J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regioselectivity of thiouracil alkylation: Application to optimization of Darapladib synthesis.
    Guibbal F; Bénard S; Patché J; Meneyrol V; Couprie J; Yong-Sang J; Meilhac O; Jestin E
    Bioorg Med Chem Lett; 2018 Feb; 28(4):787-792. PubMed ID: 29336874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Lp-PLA2 in lipid-lowering therapy.
    Racherla S; Arora R
    Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone I alleviates insulin resistance in type 2 diabetes mellitus rats through IRS-1 pathway.
    Wei Y; Gao J; Qin L; Xu Y; Wang D; Shi H; Xu T; Liu T
    Biomed Pharmacother; 2017 Sep; 93():352-358. PubMed ID: 28651236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.